| scholarly article | Q13442814 |
| P50 | author | Jens H. Kuhn | Q37367553 |
| Doris G. Leung | Q53127724 | ||
| Christine Schnitzler | Q67461016 | ||
| P2093 | author name string | C Gerard | |
| H Choe | |||
| M Farzan | |||
| N P Gerard | |||
| N Vasilieva | |||
| P2860 | cites work | Chimeric receptors of the human C3a receptor and C5a receptor (CD88) | Q22009065 |
| Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2 | Q24313018 | ||
| Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in Caenorhabditis elegans | Q28115054 | ||
| C5A anaphylatoxin and its seven transmembrane-segment receptor | Q28243792 | ||
| Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin | Q28268382 | ||
| The chemotactic receptor for human C5a anaphylatoxin | Q28280054 | ||
| CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin | Q28287108 | ||
| Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 | Q28344310 | ||
| Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis | Q33829523 | ||
| Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors | Q35034275 | ||
| ACTH: a short introductory review | Q37824466 | ||
| The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. | Q38311303 | ||
| Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor | Q38311633 | ||
| HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. | Q39000361 | ||
| Tyrosine sulfation and the secretory pathway | Q39644463 | ||
| Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region | Q40846584 | ||
| Probing the "message:address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments | Q41323110 | ||
| The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs | Q41467390 | ||
| Specific interactions of chemoattractant factor receptors with G-proteins. | Q41553496 | ||
| Analysis of sequence requirements for protein tyrosine sulfation | Q42842888 | ||
| The pharmacophore of the human C5a anaphylatoxin | Q42844326 | ||
| A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry | Q43506030 | ||
| Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry | Q43694761 | ||
| Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. | Q64983482 | ||
| Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity | Q68937732 | ||
| Identification and synthesis of a receptor binding site of human anaphylatoxin C5a | Q70223327 | ||
| New consensus features for tyrosine O-sulfation determined by mutational analysis | Q73617827 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1059-1066 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor | |
| P478 | volume | 193 |
| Q41762604 | A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds. |
| Q35140318 | A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein |
| Q40254290 | A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection |
| Q40596880 | Analysis of post-translational CCR8 modifications and their influence on receptor activity. |
| Q36943398 | Anaphylatoxins: their role in bacterial infection and inflammation |
| Q28209329 | CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion |
| Q45990428 | Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors. |
| Q36380682 | Complement activation, regulation, and molecular basis for complement-related diseases |
| Q34987258 | Complement in allergy and asthma |
| Q50127788 | Distinguishing Sulfotyrosine Containing Peptides from their Phosphotyrosine Counterparts Using Mass Spectrometry |
| Q24669712 | Function, structure and therapeutic potential of complement C5a receptors |
| Q89634343 | Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity |
| Q80277959 | Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies |
| Q33193850 | Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry |
| Q44662346 | Molecular cloning and characterization of rainbow trout (Oncorhynchus mykiss) C5a anaphylatoxin receptor |
| Q52316238 | Neuropeptidomics of the Rat Habenular Nuclei. |
| Q33259490 | Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking |
| Q38334334 | Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. |
| Q40261449 | Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion |
| Q27684270 | Structural and functional characterization of human and murine C5a anaphylatoxins |
| Q27653982 | Structure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureus |
| Q94464354 | Studying Staphylococcal Leukocidins: A Challenging Endeavor |
| Q104501919 | Submolecular probing of the complement C5a receptor-ligand binding reveals a cooperative two-site binding mechanism |
| Q37728270 | Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10. |
| Q34215630 | Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin |
| Q33725623 | Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation |
| Q28202302 | The Biology and Enzymology of Protein Tyrosine O-Sulfation |
| Q33863754 | The Controversial C5a Receptor C5aR2: Its Role in Health and Disease |
| Q49475934 | The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered hC5a |
| Q28191538 | The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity |
| Q44238580 | The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle |
| Q24610523 | The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding |
| Q34983578 | The role of the anaphylatoxins in health and disease |
| Q38151741 | The structural role of receptor tyrosine sulfation in chemokine recognition. |
| Q44990756 | The use of membrane translocating peptides to identify sites of interaction between the C5a receptor and downstream effector proteins |
| Q37728375 | Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus |
| Q28201665 | Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors |
| Q44530442 | Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. |
| Q44106148 | Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region |
| Q38195522 | Understanding and applying tyrosine biochemical diversity |
Search more.